The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience
Motamedinia P, Keheila M, Leavitt DA, Rastinehad AR, Okeke Z, Smith AD. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience. Journal Of Endourology 2015, 30: 262-267. PMID: 26630130, DOI: 10.1089/end.2015.0248.Peer-Reviewed Original ResearchMeSH KeywordsAdjuvants, ImmunologicAdultAge FactorsAgedAged, 80 and overAntibiotics, AntineoplasticBCG VaccineCarcinoma, Transitional CellDisease ProgressionEndoscopyFemaleHumansKidney NeoplasmsKidney PelvisMaleMiddle AgedMitomycinMultivariate AnalysisNeoplasm GradingNeoplasm Recurrence, LocalNeoplasm StagingNephrectomyRetrospective StudiesRisk FactorsSurvival RateUreterUreteral NeoplasmsConceptsUpper tract urothelial carcinomaBacillus Calmette-GuérinRadical nephroureterectomyOverall survivalUrothelial carcinomaPredictors of OSLow-risk patientsMajority of patientsRisk of deathLow-grade patientsGold standard treatmentHigh-grade patientsMonths of surveillanceResectable diseaseInitial resectionEndoscopic resectionImperative indicationsMedian timeRenal preservationTumor characteristicsAdjuvant rolePercutaneous resectionRetrospective studyPercutaneous managementStandard treatment